• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合并抑制人凝血酶的单链DNA分子的筛选。

Selection of single-stranded DNA molecules that bind and inhibit human thrombin.

作者信息

Bock L C, Griffin L C, Latham J A, Vermaas E H, Toole J J

机构信息

Gilead Sciences Inc., Foster City, California 94404.

出版信息

Nature. 1992 Feb 6;355(6360):564-6. doi: 10.1038/355564a0.

DOI:10.1038/355564a0
PMID:1741036
Abstract

Aptamers are double-stranded DNA or single-stranded RNA molecules that bind specific molecular targets. Large randomly generated populations can be enriched in aptamers by in vitro selection and polymerase chain reaction. But so far single-stranded DNA has not been investigated for aptamer properties, nor has a target protein been considered that does not interact physiologically with nucleic acid. Here we describe the isolation of single-stranded DNA aptamers to the protease thrombin of the blood coagulation cascade and report binding affinities in the range 25-200 nM. Sequence data from 32 thrombin aptamers, selected from a pool of DNA containing 60 nucleotides of random sequence, displayed a highly conserved 14-17-base region. Several of these aptamers at nanomolar concentrations inhibited thrombin-catalysed fibrin-clot formation in vitro using either purified fibrinogen or human plasma.

摘要

适体是能结合特定分子靶标的双链DNA或单链RNA分子。通过体外筛选和聚合酶链反应,可以从大量随机生成的群体中富集适体。但迄今为止,尚未对单链DNA的适体特性进行研究,也未考虑过与核酸无生理相互作用的靶蛋白。在此,我们描述了针对凝血级联中的蛋白酶凝血酶的单链DNA适体的分离,并报告了其结合亲和力在25 - 200 nM范围内。从含有60个随机序列核苷酸的DNA库中筛选出的32种凝血酶适体的序列数据显示,有一个高度保守的14 - 17个碱基的区域。其中几种适体在纳摩尔浓度下,使用纯化的纤维蛋白原或人血浆,在体外抑制了凝血酶催化的纤维蛋白凝块形成。

相似文献

1
Selection of single-stranded DNA molecules that bind and inhibit human thrombin.结合并抑制人凝血酶的单链DNA分子的筛选。
Nature. 1992 Feb 6;355(6360):564-6. doi: 10.1038/355564a0.
2
Oligonucleotide inhibitors of human thrombin that bind distinct epitopes.结合不同表位的人凝血酶的寡核苷酸抑制剂。
J Mol Biol. 1997 Oct 10;272(5):688-98. doi: 10.1006/jmbi.1997.1275.
3
Generation of species cross-reactive aptamers using "toggle" SELEX.使用“切换”SELEX技术生成物种交叉反应性适配体。
Mol Ther. 2001 Dec;4(6):567-73. doi: 10.1006/mthe.2001.0495.
4
Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro.从去纤苷中分离和鉴定在体外作为凝血酶拮抗剂的适体。
Biochem Biophys Res Commun. 1994 Apr 29;200(2):933-7. doi: 10.1006/bbrc.1994.1539.
5
RNA aptamers specific for bovine thrombin.对牛凝血酶具有特异性的RNA适配体。
J Mol Recognit. 2003 Jan-Feb;16(1):23-7. doi: 10.1002/jmr.604.
6
Screening of functional antidotes of RNA aptamers against bovine thrombin.针对牛凝血酶的RNA适配体功能解毒剂的筛选。
FEBS Lett. 2004 Mar 26;562(1-3):125-8. doi: 10.1016/S0014-5793(04)00197-8.
7
Thrombin inhibitors based on single-stranded DNA aptamers.基于单链DNA适配体的凝血酶抑制剂。
Blood Coagul Fibrinolysis. 2014 Jan;25(1):39-45. doi: 10.1097/MBC.0b013e32836577f3.
8
Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures.体外筛选可折叠成特定配体结合结构的单链DNA分子。
Nature. 1992 Feb 27;355(6363):850-2. doi: 10.1038/355850a0.
9
ssDNA aptamers that selectively bind oxytetracycline.选择性结合土霉素的单链DNA适配体。
Bioorg Med Chem. 2008 Feb 1;16(3):1254-61. doi: 10.1016/j.bmc.2007.10.073. Epub 2007 Nov 7.
10
Development of a novel DNA sensing system using DNA aptamer inhibited enzymatic activity 1.利用DNA适配体抑制酶活性开发新型DNA传感系统1。
Nucleic Acids Symp Ser (Oxf). 2004(48):231-2. doi: 10.1093/nass/48.1.231.

引用本文的文献

1
Aptamers Targeting Immune Checkpoints for Tumor Immunotherapy.用于肿瘤免疫治疗的靶向免疫检查点的适配体
Pharmaceutics. 2025 Jul 22;17(8):948. doi: 10.3390/pharmaceutics17080948.
2
Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomised phase IIa clinical trial (RCT).罗武那他宾(也称为BC007)对新冠后综合征患者疲劳及生活质量的安全性、耐受性和临床效果(reCOVer):一项前瞻性、探索性、安慰剂对照、双盲、随机IIa期临床试验(RCT)
EClinicalMedicine. 2025 Jul 22;86:103358. doi: 10.1016/j.eclinm.2025.103358. eCollection 2025 Aug.
3
Phase Separation Oppositely Modulates G-quadruplex and i-Motif DNA Folding in the Nuclei of Living Cells.
相分离对活细胞核中G-四链体和i-基序DNA折叠起相反的调节作用。
bioRxiv. 2025 Jul 4:2025.06.30.661982. doi: 10.1101/2025.06.30.661982.
4
Tandem ssDNA in neutrophil extracellular traps binds thrombin and regulates immunothrombosis.中性粒细胞胞外诱捕网中的串联单链DNA结合凝血酶并调节免疫血栓形成。
Proc Natl Acad Sci U S A. 2025 Jul 8;122(27):e2418191122. doi: 10.1073/pnas.2418191122. Epub 2025 Jul 3.
5
Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery.适体的SELEX技术进展及其在治疗和药物递送中的新兴应用
Biomolecules. 2025 Jun 5;15(6):818. doi: 10.3390/biom15060818.
6
Surface Plasmon Resonance Aptasensors: Emerging Design and Deployment Landscape.表面等离子体共振适体传感器:新兴的设计与应用前景
Biosensors (Basel). 2025 Jun 4;15(6):359. doi: 10.3390/bios15060359.
7
Advantages, applications, and future directions of aptamer SELEX: A review.适体指数富集的配体系统进化技术的优势、应用及未来方向:综述
Mol Ther Nucleic Acids. 2025 May 26;36(3):102575. doi: 10.1016/j.omtn.2025.102575. eCollection 2025 Sep 9.
8
DNA-triggered activation of aptamer-neutralized enzyme for formation of injectable hydrogel.DNA触发的适配体中和酶激活以形成可注射水凝胶。
Nanoscale Horiz. 2025 Jul 21;10(8):1703-1716. doi: 10.1039/d5nh00314h.
9
Antibody and aptamer-based therapies for osteoarthritis: Application of antibodies and promise of aptamers.基于抗体和适配体的骨关节炎治疗方法:抗体的应用及适配体的前景。
Mol Ther Nucleic Acids. 2025 May 5;36(2):102552. doi: 10.1016/j.omtn.2025.102552. eCollection 2025 Jun 10.
10
Structural basis of G-quadruplex recognition by a camelid antibody fragment.骆驼科抗体片段识别G-四链体的结构基础
Nucleic Acids Res. 2025 May 22;53(10). doi: 10.1093/nar/gkaf453.